Digital Content 
NEWS #PharmaBuzz
29 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-29/bionxt-reports-sublingual-cladribine-multiple-sclerosis-drug-milestones-including-large-animal-study
17 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250917584069/en/EMD-Serono-to-Present-New-Data-Highlighting-Durable-Effects-of-MAVENCLAD-in-Relapsing-Multiple-Sclerosis-RMS-at-ECTRIMS-2025
17 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250917717443/en/Merck-to-Present-New-Data-Highlighting-Durable-Effects-of-MAVENCLAD-in-Relapsing-Multiple-Sclerosis-RMS-at-ECTRIMS-2025
05 Aug 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-solutions-reports-pending-patent-grants-in-europe-and-eurasia-1056552
07 Jul 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxts-sublingual-cladribine-program-for-ms-ready-for-next-phase-1046096
30 Aug 2024
// BUSINESSWIRE
Share 